熊貓乳品(300898.SZ):前三季度淨利預增49.40%-65.13%
格隆匯10月14日丨熊貓乳品(300898.SZ)披露2021年前三季度業績預吿,預計2021年1-9月實現歸屬於上市公司股東的淨利潤5700萬元-6300萬元,同比增長49.40%-65.13%。業績預增原因系:
報吿期內,公司依據董事會制定的發展戰略及經營計劃,開發新客户、研發新產品。隨着目標市場佔有率的逐步提升,公司主營業務持續穩定向好,實現了銷售收入及淨利潤的穩步增長。
預計公司2021年前三季度非經常性損益對公司淨利潤的影響金額約為1000萬元,主要系公司收到政府補助和理財收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.